ICV administration of CRF blocker (CRF9-41 δ helical) reduces morphine withdrawal in rats

被引:13
作者
Brugger, S
Sanchez, R
Brugger, AJ
Martinez, JA [1 ]
机构
[1] Univ Murcia, Sch Med, Pharmacol Unit, Dept Physiol & Pharmacol, Murcia 30700, Spain
[2] Gen Hosp, Dept Psychiat, Albacete, Spain
关键词
CRF9-41 delta helical antagonist; hypothalamo - pituitary-adrenal axis; morphine withdrawal syndrome; opoid;
D O I
10.1016/S0278-5846(98)00039-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
1. The effects of CRF9-41 partial derivative helical on morphine withdrawal signs in rats were studied 2. Intracerebroventricular administration of CRF9-41 partial derivative helical 5 at 10 mu g/kg reduced central and peripheral symptons of the withdrawal syndrome, such as ptosis, jumping, wet dog shakes and teeth chatering; other signs remained unchanged. The effect were not dose dependent. 3. The hypothermi characteristic of the Withdrawal sindrome was reduced by CRF9-41 partial derivative helical. 4. These results suggest that the hypothalamo pituitary adrenal(HPA) axis play an important role in the morphine withdrawal syndrome in rats.
引用
收藏
页码:775 / 785
页数:11
相关论文
共 26 条
[11]  
FREDERICKSON RCA, 1975, J PHARMACOL EXP THER, V193, P44
[12]  
FRENCH ED, 1978, SOC NEUR ABSTR, V4, P408
[13]   BETA-ENDORPHIN-LIKE IMMUNOREACTIVITY IN PLASMA, PITUITARIES AND HYPOTHALAMUS OF RATS FOLLOWING TREATMENT WITH OPIATES [J].
HOLLT, V ;
PRZEWLOCKI, R ;
HERZ, A .
LIFE SCIENCES, 1978, 23 (10) :1057-1066
[14]  
IGNAR D, 1990, BRAIN RES, V435, P220
[15]   ELECTRON-MICROSCOPIC ANALYSIS OF TYROSINE-HYDROXYLASE, DOPAMINE-BETA-HYDROXYLASE AND PHENYLETHANOLAMINE-N-METHYL-TRANSFERASE IMMUNOREACTIVE INNERVATION OF THE HYPOTHALAMIC PARAVENTRICULAR NUCLEUS IN THE RAT [J].
LIPOSITS, Z ;
PHELIX, C ;
PAULL, WK .
HISTOCHEMISTRY, 1986, 84 (02) :105-120
[16]   CRF(2-ALPHA) AND CRF(2-BETA) RECEPTOR MESSENGER-RNAS ARE DIFFERENTIALLY DISTRIBUTED BETWEEN THE RAT CENTRAL-NERVOUS-SYSTEM AND PERIPHERAL-TISSUES [J].
LOVENBERG, TW ;
CHALMERS, DT ;
LIU, CG ;
DESOUZA, EB .
ENDOCRINOLOGY, 1995, 136 (09) :4139-4142
[17]  
MALDONADO R, 1992, J PHARMACOL EXP THER, V261, P669
[18]   COMPARISON OF SELECTIVE AND COMPLETE INHIBITORS OF ENKEPHALIN-DEGRADING ENZYMES ON MORPHINE WITHDRAWAL SYNDROME [J].
MALDONADO, R ;
DAUGE, V ;
CALLEBERT, J ;
VILLETTE, JM ;
FOURNIEZALUSKI, MC ;
FEGER, J ;
ROQUES, BP .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 165 (2-3) :199-207
[19]   PLASMA BETA-ENDORPHIN AND CORTISOL-LEVELS IN MORPHINE-TOLERANT RATS AND IN NALOXONE-INDUCED WITHDRAWAL [J].
MARTINEZ, JA ;
VARGAS, ML ;
FUENTE, T ;
GARCIA, JD ;
MILANES, MV .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 182 (01) :117-123
[20]   L-TYPE CA-2+ CHANNEL LIGANDS MODULATE MORPHINE EFFECTS ON THE HYPOTHALAMUS-PITUITARY-ADRENOCORTICAL AXIS IN RATS [J].
MARTINEZPINERO, MG ;
VARGAS, ML ;
MILANES, MV .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 232 (2-3) :191-198